Functional Connectivity and Response to Ketamine Therapy in Treatment-Resistant Depression: A Pilot Study

被引：0
|
作者：
Vasavada, Megha [1 ]
Leaver, Amber [1 ]
Loureiro, Joana [1 ]
Espinoza, Randall [1 ]
Joshi, Shantanu [1 ]
Njau, Stephanie [1 ]
Wade, Benjamin [1 ]
Kubicki, Antoni [1 ]
Congdon, Eliza [1 ]
Narr, Katherine [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
BIOLOGICAL PSYCHIATRY | 2018年 / 83卷 / 09期
关键词：
Ketamine; Major Depressive Disorder (MDD); Resting State fMRI; Default Mode Network;
D O I：
10.1016/j.biopsych.2018.02.753
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
F139
引用
收藏
页码：S292 / S292
页数：1
相关论文
共 50 条
  • [31] Functional Connectivity Subtypes During a Positive Mood Induction: Predicting Clinical Response in a Randomized Controlled Trial of Ketamine for Treatment-Resistant Depression
    Hossein, Shabnam
    Woody, Mary L.
    Panny, Benjamin
    Spotts, Crystal
    Wallace, Meredith L.
    Mathew, Sanjay J.
    Howland, Robert H.
    Price, Rebecca B.
    JOURNAL OF PSYCHOPATHOLOGY AND CLINICAL SCIENCE, 2024,
  • [32] A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression
    Zheng, Wei
    Zhou, Yan-Ling
    Liu, Wei-Jian
    Wang, Cheng-Yu
    Zhan, Yan-Ni
    Lan, Xiao-Feng
    Zhang, Bin
    Ning, Yu-Ping
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 275 : 38 - 43
  • [33] The cortisol awakening response in treatment-resistant depression is not a biomarker of the clinical response to ketamine
    Naughton, M.
    Allen, A. P.
    Clarke, G.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    Cryan, J. F.
    Dinan, T. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S401 - S401
  • [34] Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression
    Liebrenz, Michael
    Stohler, Rudolf
    Borgeat, Alain
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (04): : 640 - 643
  • [35] Neural Correlates of Treatment Response to Intravenous Ketamine in Adolescents With Treatment-Resistant Depression
    Cullen, Kathryn
    Klimes-Dougan, Bonnie
    Amatya, Palistha
    Thai, Michelle
    Schreiner, Melinda Westlund
    Roback, Mark
    Albott, Sophia
    Ren, Yanan
    Eberly, Lynn
    Lim, Kelvin
    Mueller, Bryon
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S179 - S180
  • [36] Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage
    Scheele, Dirk
    Zimbal, Sophia
    Feinstein, Justin S.
    Delis, Achilles
    Neumann, Claudia
    Mielacher, Clemens
    Philipsen, Alexandra
    Hurlemann, Rene
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (12): : 982 - 986
  • [37] Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression
    Del Sant, L. C.
    Magalhaes, E.
    Lucchese, A. C.
    Palhares Alves, H. N.
    Sarin, L. M.
    Del Porto, J. A.
    Tavares de lacerda, A. L.
    EUROPEAN PSYCHIATRY, 2017, 41 : S525 - S526
  • [38] A systematic review of ketamine for treatment-resistant depression
    Patel, Reshmee
    Loh, Feng-Hua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 132 - 132
  • [39] The use of subcutaneous ketamine for treatment-resistant depression
    Vargas Alves Nunes, A.
    Carrara, E.
    Odebrecht Vargas Nunes, S.
    Fernandes Jorge, I.
    Alves, E.
    Haddad, M.
    EUROPEAN PSYCHIATRY, 2019, 56 : S95 - S95
  • [40] Feasibility of continuation ketamine for treatment-resistant depression
    aan het Rot, Marije
    Mathew, Sanjay J.
    Collins, Katherine A.
    Perez, Andrew M.
    Murrough, James W.
    Reich, David L.
    Charney, Dennis S.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 220S - 220S
12345